Notably, the neutralization of CCL3 reduces pain-like behavior development in STZ- [19], paclitaxel- [22], CCI- [57], and PSNL-induced [21] neuropathy in mice, which may indicate its significant role in this pathology. The gene discussed is CCL3; the disease is neuropathy.